Abiopharma

News list

Badawi David 🔴 sold 8.2K shares of Sight Sciences, Inc. (SGHT) at $3.48 Transaction Date: Apr 02, 2026 | Filing ID: 142233

Full text

News bot April 3, 2026, 8:29 p.m.
🔍 Badawi David (Executive)

Company: Sight Sciences, Inc. (SGHT)

Report Date: 2026-04-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 8,168
Detailed Transactions and Holdings:
- Sold 8,168 shares of Common Stock at $3.48 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: false | shares_owned_after: 1,990,290.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
- F2: Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3: Includes (i) 1,804,359 shares of common stock, and (ii) 185,931 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested.